組織マイクロアレイの世界市場レポート 2025年

組織マイクロアレイの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.2％で209億5,000万米ドルに成長します。予測期間の成長は、デジタルパソロジーの出現、アプリケーションの拡大、バイオ医薬品産業の成長、規制支援と標準化、aiと機械学習の統合に起因すると考えられます。予測期間の主な動向には、イメージング技術の進歩、3d組織マイクロアレイの開発、ハイコンテンツスクリーニング、標準化への取り組み、単一細胞解析の統合などが含まれます。

がんの罹患率の増加は、今後の組織マイクロアレイ市場の成長を促進すると予想されます。がんは、異常な細胞が制御不能に増殖し、正常な境界を侵し、他の臓器への転移や近隣組織への浸潤の可能性がある場合に、あらゆる臓器や組織に発生する可能性のあるさまざまな疾患を包含します。組織マイクロアレイは腫瘍学において、異なる腫瘍サンプルにおけるがん関連バイオマーカーの発現を解析するために利用されています。例えば、2022年6月、英国を拠点とするがん慈善団体マクミラン・キャンサー・サポートが発表したデータによると、がん患者数は2022年には300万人に達し、英国では2025年には350万人近く、2030年には400万人に増加するとの予測が出ています。したがって、がん患者数の増加が組織マイクロアレイ市場の成長を牽引しています。

組織マイクロアレイ市場の成長には、個別化医療に対する需要の高まりがさらに拍車をかけています。個別化医療は、より効果的なヘルスケアのために、個人の特性に合わせた治療を行うものです。組織マイクロアレイは、複数の組織サンプルを同時に分析するのに役立ち、バイオマーカーの迅速な評価を促進します。2022年、食品医薬品局（FDA）の医薬品評価研究センター（CDER）は37の新規分子化合物（NME）を承認し、その約34％は個別化医療に分類されました。このことは、個別化医療を進める上で組織マイクロアレイが不可欠な役割を担っていることを強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界組織マイクロアレイ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の組織マイクロアレイ市場：成長率分析
• 世界の組織マイクロアレイ市場の実績：規模と成長, 2019-2024
• 世界の組織マイクロアレイ市場の予測：規模と成長, 2024-2029, 2034F
• 世界組織マイクロアレイ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の組織マイクロアレイ市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫組織化学
• 蛍光in situハイブリダイゼーション
• 凍結組織アレイ
• その他のタイプ
• 世界の組織マイクロアレイ市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デオキシリボ核酸（DNA）マイクロアレイ
• ポリメラーゼ連鎖反応（PCR）
• 次世代シーケンシング
• ノーザンブロッティング
• ウエスタンブロッティング
• 世界の組織マイクロアレイ市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 遺伝子発現プロファイリング
• 一塩基多型（SNP）検出
• 二本鎖B-DNAマイクロアレイ
• 比較ゲノムハイブリダイゼーション
• シーケンシングバイオインフォマティクス
• 世界の組織マイクロアレイ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 調査組織
• 病院
• 世界の組織マイクロアレイ市場、免疫組織化学のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動免疫組織化学
• 手動免疫組織化学
• マルチプレックス免疫組織化学
• 世界の組織マイクロアレイ市場、蛍光in situハイブリダイゼーション（FISH）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単色魚
• マルチカラーフィッシュ
• DNAフィッシュ
• 世界の組織マイクロアレイ市場凍結組織アレイのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 組織マイクロアレイ冷凍サンプルより
• 瞬間凍結組織アレイ
• 世界の組織マイクロアレイ市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 核酸マイクロアレイ
• RNAインサイチューハイブリダイゼーション
• パラフィン包埋組織アレイ

第7章 地域別・国別分析

• 世界の組織マイクロアレイ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の組織マイクロアレイ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 組織マイクロアレイ市場：競合情勢
• 組織マイクロアレイ市場：企業プロファイル
  • Roche Group Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson Biosciences Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Qiagen NV
• PerkinElmer Inc.
• Bio-Techne Corporation
• Tristar Group
• Evotec SE
• Precision For Medicine Inc.
• Molecular Devices LLC
• BioIVT LLC
• BioChain Institute Inc.
• Creative Bioarray Co
• 3DHISTECH Ltd.
• Novus Biologicals LLC
• PREMIER Biosoft International Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 組織マイクロアレイ市場2029：新たな機会を提供する国
• 組織マイクロアレイ市場2029：新たな機会を提供するセグメント
• 組織マイクロアレイ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

The tissue microarray research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including the tissue microarray industry's global market size, regional shares, competitors with tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue microarray market size has grown strongly in recent years. It will grow from $12.05 billion in 2024 to $13.23 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rise of precision medicine, drug discovery and development, efficient analysis, rising prevalence of chronic diseases, biobanking initiatives

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $20.95 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to emergence of digital pathology, expanded applications, growing biopharmaceutical industry, regulatory support and standards, ai and machine learning integration. Major trends in the forecast period include advancements in imaging technologies, development of 3d tissue microarrays, high-content screening, standardization initiatives, and single-cell analysis integration.

The increasing incidence of cancer is expected to drive the growth of the tissue microarray market in the future. Cancer encompasses a range of diseases that can arise in any organ or tissue when abnormal cells multiply uncontrollably, breach their normal boundaries, and potentially spread to other organs or invade nearby tissues. Tissue microarrays are utilized in oncology to analyze the expression of cancer-related biomarkers in different tumor samples. For example, in June 2022, data published by Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022, with projections suggesting it will rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the increasing number of cancer cases is driving the growth of the tissue microarray market.

The growth of the tissue microarray market is further fueled by the rising demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics for more effective healthcare. Tissue microarrays are instrumental in analyzing multiple tissue samples concurrently, facilitating rapid assessment of biomarkers. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines. This emphasizes the integral role of tissue microarrays in advancing personalized medicine.

A notable trend in the tissue microarray market is the emergence of strategic partnerships. Major companies in the market are forming alliances to develop innovative tissue microarray technologies. For instance, The Cureline Group partnered with Cellecta Inc. to launch Tissue 2 Target Services, combining their competencies in molecular analysis and biospecimen management. Another collaboration involves Ultivue Inc. and ngTMA, aiming to advance multiplexed immunofluorescence assays and apply new tissue microarray technologies for spatial analysis in scientific research.

Companies in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. MARGenomics launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform, the first in Europe and the United States to receive regulatory approval for diagnostic purposes. This platform, funded by the Carlos III Health Institute and the European Union's NextGenerationEU initiative, offers diverse functionalities for genomic and expression microarrays.

In November 2022, The Cureline Group, a US-based company specializing in preclinical and clinical research services, announced a partnership with Cellecta Inc. to launch Tissue 2 Target, which aims to enhance preclinical and translational research workflows. This collaboration will create a comprehensive resource for researchers focused on gene target and biomarker discovery, streamlining the molecular characterization of high-quality human biospecimens. By leveraging The Cureline Group's expertise in biospecimen management alongside Cellecta's functional genomics techniques, the partnership seeks to facilitate evidence-based decision-making, ultimately improving the outcomes of translational and preclinical programs. Cellecta, Inc., also based in the US, specializes in functional genomics and offers innovative tools for RNA interference and CRISPR-based research.

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
• 2) By Technology: Deoxyribonucleic Acid (DNA) Microarray; Polymerase Chain Reaction (PCR); Next-Generation Sequencing; Northern Blotting; Western Blotting
• 3) By Application: Oncology; Gene Expression Profiling; Single Nucleotide Polymorphism (SNP) Detection; Double-Stranded B-DNA Microarrays; Comparative Genomic Hybridization; Sequencing Bioinformatics
• 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organization; Hospitals
• Subsegments:
• 1) By Immunohistochemistry: Automated Immunohistochemistry; Manual Immunohistochemistry; Multiplex Immunohistochemistry
• 2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH; Multi-Color FISH; DNA FISH
• 3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples; Snap-Frozen Tissue Array
• 4) By Other Types: Nucleic Acid Microarrays; RNA In Situ Hybridization; Paraffin-Embedded Tissue Array
• Companies Mentioned: Roche Group; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Becton, Dickinson Biosciences; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Microarray Market Characteristics

3. Tissue Microarray Market Trends And Strategies

4. Tissue Microarray Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Tissue Microarray Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Microarray Market Growth Rate Analysis
• 5.4. Global Tissue Microarray Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Microarray Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Microarray Total Addressable Market (TAM)

6. Tissue Microarray Market Segmentation

• 6.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immunohistochemistry
• Fluorescent In Situ Hybridization
• Frozen Tissue Array
• Other Types
• 6.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid (DNA) Microarray
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Northern Blotting
• Western Blotting
• 6.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Gene Expression Profilinng
• Single Nucleotide Polymorphism (SNP) Detection
• Double-Stranded B-DNA Microarrays
• Comparative Genomic Hybridization
• Sequencing Bioinformatics
• 6.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnological Companies
• Research Organization
• Hospitals
• 6.5. Global Tissue Microarray Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Automated Immunohistochemistry
• Manual Immunohistochemistry
• Multiplex Immunohistochemistry
• 6.6. Global Tissue Microarray Market, Sub-Segmentation Of Fluorescent In Situ Hybridization (FISH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Color FISH
• Multi-Color FISH
• DNA FISH
• 6.7. Global Tissue Microarray Market, Sub-Segmentation Of Frozen Tissue Array,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tissue Microarray from Frozen Samples
• Snap-Frozen Tissue Array
• 6.8. Global Tissue Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Microarrays
• RNA In Situ Hybridization
• Paraffin-Embedded Tissue Array

7. Tissue Microarray Market Regional And Country Analysis

• 7.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Microarray Market

• 8.1. Asia-Pacific Tissue Microarray Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Microarray Market

• 9.1. China Tissue Microarray Market Overview
• 9.2. China Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Microarray Market

• 10.1. India Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Microarray Market

• 11.1. Japan Tissue Microarray Market Overview
• 11.2. Japan Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Microarray Market

• 12.1. Australia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Microarray Market

• 13.1. Indonesia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Microarray Market

• 14.1. South Korea Tissue Microarray Market Overview
• 14.2. South Korea Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Microarray Market

• 15.1. Western Europe Tissue Microarray Market Overview
• 15.2. Western Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Microarray Market

• 16.1. UK Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Microarray Market

• 17.1. Germany Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Microarray Market

• 18.1. France Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Microarray Market

• 19.1. Italy Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Microarray Market

• 20.1. Spain Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Microarray Market

• 21.1. Eastern Europe Tissue Microarray Market Overview
• 21.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Microarray Market

• 22.1. Russia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Microarray Market

• 23.1. North America Tissue Microarray Market Overview
• 23.2. North America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Microarray Market

• 24.1. USA Tissue Microarray Market Overview
• 24.2. USA Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Microarray Market

• 25.1. Canada Tissue Microarray Market Overview
• 25.2. Canada Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Microarray Market

• 26.1. South America Tissue Microarray Market Overview
• 26.2. South America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Microarray Market

• 27.1. Brazil Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Microarray Market

• 28.1. Middle East Tissue Microarray Market Overview
• 28.2. Middle East Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Microarray Market

• 29.1. Africa Tissue Microarray Market Overview
• 29.2. Africa Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Microarray Market Competitive Landscape And Company Profiles

• 30.1. Tissue Microarray Market Competitive Landscape
• 30.2. Tissue Microarray Market Company Profiles
  • 30.2.1. Roche Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton, Dickinson Biosciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Microarray Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Qiagen NV
• 31.4. PerkinElmer Inc.
• 31.5. Bio-Techne Corporation
• 31.6. Tristar Group
• 31.7. Evotec SE
• 31.8. Precision For Medicine Inc.
• 31.9. Molecular Devices LLC
• 31.10. BioIVT LLC
• 31.11. BioChain Institute Inc.
• 31.12. Creative Bioarray Co
• 31.13. 3DHISTECH Ltd.
• 31.14. Novus Biologicals LLC
• 31.15. PREMIER Biosoft International Inc.

32. Global Tissue Microarray Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Microarray Market

34. Recent Developments In The Tissue Microarray Market

35. Tissue Microarray Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Microarray Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Microarray Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Microarray Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer